The Joint Corp. (JYNT)
NASDAQ: JYNT · Real-Time Price · USD
11.16
-0.19 (-1.67%)
Nov 21, 2024, 10:47 AM EST - Market open
The Joint Revenue
The Joint had revenue of $30.20M in the quarter ending September 30, 2024, with 2.46% growth. This brings the company's revenue in the last twelve months to $120.80M, up 5.26% year-over-year. In the year 2023, The Joint had annual revenue of $117.70M with 16.24% growth.
Revenue (ttm)
$120.80M
Revenue Growth
+5.26%
P/S Ratio
1.40
Revenue / Employee
$152,136
Employees
794
Market Cap
167.22M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 117.70M | 16.44M | 16.24% |
| Dec 31, 2022 | 101.25M | 21.24M | 26.55% |
| Dec 31, 2021 | 80.01M | 21.33M | 36.34% |
| Dec 31, 2020 | 58.68M | 10.23M | 21.12% |
| Dec 31, 2019 | 48.45M | 11.79M | 32.16% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Adaptimmune Therapeutics | 175.04M |
| Heron Therapeutics | 137.74M |
| Biodesix | 65.56M |
| scPharmaceuticals | 30.28M |
| Stereotaxis | 25.14M |
| Verastem | 10.00M |
JYNT News
- 12 days ago - The Joint Corp. (JYNT) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 23 days ago - The Joint Chiropractic is Named the Official Chiropractor of Grand Canyon University Athletics - PRNewsWire
- 4 weeks ago - The Joint Corp. to Host Conference Call on Thursday, November 7th to Discuss Third Quarter 2024 Results - GlobeNewsWire
- 5 weeks ago - The Joint Corp. Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - The Joint Corp. Appoints Sanjiv Razdan President and Chief Executive Officer - GlobeNewsWire
- 6 weeks ago - The Joint Chiropractic Ranks No. 150 on the Franchise Times Top 400 - PRNewsWire
- 6 weeks ago - The Joint Chiropractic Celebrates 25 Years of Making Quality Chiropractic Care Accessible - PRNewsWire
- 2 months ago - The Joint Corp. Announces New Senior Vice President of Human Resources - PRNewsWire